PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIROCYCLOHEXANE-1,1'-PYRANO3,4,bINDOL-4-AMINE AND A PROPIONIC ACID DERIVATIVE SELECTED FROM THE GROUP CONSISTING OF IBUPROFEN AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF AND KIT COMPRISING SAID COMPOUNDS

摘要

The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient, which is selected from (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient, which is a propionic acid derivative selected from the group consisting of ibuprofen and the physiologically acceptable salts thereof. The invention also relates to a kit comprising said compounds.